October 9, 2018 |
October 9, 2018 ― Trinity Biotech plc (Nasdaq: TRIB) has completed its build out of new laboratory facilities at 10 Earhart Drive, Buffalo, NY 14221. This location will serve as headquarters for the Immco Diagnostics Reference Laboratory (www.immco.com), acquired by Trinity in 2013.
The Immco Reference Laboratory has demonstrated consistent growth since acquisition, largely driven by esoteric and proprietary autoimmune diagnostics such as the Sjö panel of testing supporting early diagnosis of Sjögren’s Syndrome. Operational needs simply outgrew the space available in Buffalo’s Innovation Center requiring relocation. The new facility will more than double the size of Immco laboratory facilities. Between laboratory and manufacturing Immco will occupy 31,000 square feet at 10 Earhart.
“Trinity management has been working toward establishing its new laboratory headquarters in a significantly upgraded technology center for two years,” said Kevin Lawson, Immco’s Commercial Officer. “Our team has delivered a platform enabling us to meet the increasing demand for innovative autoimmune diagnostics and integrate new technologies and test categories supporting revenue growth for years to come. This facility allows us to better work with each other and, more importantly, better serve our customers.”
For More Information:
+1-691-0091 ext. 300